(1 - 31 von 67
)
$1.5B deal: AstraZeneca sells U.S. rights to respiratory medicine
www.bizjournals.com
— Sobi President and CEO Guido Oelkers said his company is excited about adding Synagis to its product. [Synagis] remains the only product ... › news
Guido Oelkers neuer CEO und Präsident bei Sobi, Swedish Orphan...
www.lifepr.de
(lifePR) (Langen, ) Swedish Orphan Biovitrum AB (SobiTM) ernennt Guido Oelkers zum Präsident und Chief Executive Officer. Am 22. Mai hat er die Nachfolge von Geoffrey McDonough ...
Guido Oelkers Appointed President and CEO at Sobi | Marketsfinance.sunnyvale.com › read › gu...
finance.sunnyvale.com
Guido Oelkers joins Sobi from his previous role as CEO at BSN Medical GmbH as Nycomed, DKSH Group and Aventis (formerly Hoechst), where he began ... Guido Oelkers was born in and holds a PhD in Strategic Management ... We also market a portfolio of speciality and rare disease products ...
Hilde Furberg, Guido Oelkers | GenomeWeb
www.genomeweb.com
In addition, Blueprint has appointed Guido Oelkers as a senior advisor to the firm. Oelkers currently serves as CEO of Swedish Orphan Biovitirum. Previously, he ...
sortiert nach Relevanz / Datum